Drug Guide

Generic Name

Clotrimazole

Brand Names Lotrimin, Gyne-lotrimin, Mycelex, Mycelex-7, Mycelex-g, Gyne-lotrimin Combination Pack, Mycelex-7 Combination Pack, Gyne-lotrimin 3, Gyne-lotrimin 3 Combination Pack, Lotrimin Af, Trivagizole 3, Gynix

Classification

Therapeutic: Antifungal

Pharmacological: Imidazole antifungal agent

FDA Approved Indications

Mechanism of Action

Clotrimazole inhibits fungal cytochrome P450-dependent 14α-demethylase, resulting in decreased ergosterol synthesis and disruption of fungal cell membrane formation, leading to leakage of cell contents and fungal cell death.

Dosage and Administration

Adult: For vaginal candidiasis, one applicatorful (100 mg) intravaginally once daily for 7 days; for cutaneous infections, apply a thin layer to affected area twice daily for 2-4 weeks.

Pediatric: Use as directed by a healthcare provider; typically similar dosing for vaginal candidiasis, but consult specific guidelines.

Geriatric: No dose adjustment generally required; monitor for skin integrity and use in conjunction with renal or hepatic impairment as needed.

Renal Impairment: No specific adjustment needed, but caution advised.

Hepatic Impairment: No specific adjustment needed, but caution advised.

Pharmacokinetics

Absorption: Minimal systemic absorption when used topically; significant absorption when administered via oral or vaginal routes.

Distribution: Widely distributed in body tissues, especially skin and mucous membranes.

Metabolism: Metabolized in the liver via cytochrome P450 enzymes.

Excretion: Excreted mainly in urine, primarily as inactive metabolites.

Half Life: Approximately 3-4 hours when absorbed systemically.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for signs of allergic reactions or skin irritation; assess affected areas for improvement.

Diagnoses:

  • Risk for infection
  • Impaired skin integrity

Implementation: Educate patient on proper application, hygiene, and adherence to therapy schedule.

Evaluation: Assess for reduction in signs and symptoms of infection.

Patient/Family Teaching

Special Considerations

Black Box Warnings: N/A

Genetic Factors: No known genetic factors affecting use.

Lab Test Interference: None reported.

Overdose Management

Signs/Symptoms: Nausea, vomiting, or gastrointestinal discomfort if swallowed in excess; local irritation if topical overdose.

Treatment: Supportive care; no specific antidote. Remove unabsorbed drug/application and provide symptomatic relief.

Storage and Handling

Storage: Store at room temperature, protected from light and moisture.

Stability: Stable until expiration date when stored properly.

This guide is for educational purposes only and is not intended for clinical use.